________________________________________________________
____EntRel____
236
2
____Arg1____
159..234
1
#### Text ####
LUTHER BURBANK CROSS-BRED PLANTS to produce the billion-dollar Idaho potato
##############
____Arg2____
236..337
2
#### Text ####
Bioengineers set out to duplicate that feat -- scientifically and commercially -- with new life forms
##############
________________________________________________________
________________________________________________________
____Implicit____
469
4
#### Features ####
Wr, Comm, Null, Null
then, Temporal.Asynchronous.Precedence
____Arg1____
341..467
3
#### Text ####
In 1953, James Watson and his colleagues unlocked the double helix of DNA (deoxyribonucleic acid), the genetic key to heredity
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
469..647
4
#### Text ####
Twenty years later, two California academics, Stanley Cohen and Herbert Boyer, made "recombinant" DNA, transplanting a toad's gene into bacteria, which then reproduced toad genes
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Explicit____
621..625
4,3,3,1,2,1,2,1,0
#### Text ####
then
##############
#### Features ####
Wr, Comm, Null, Null
then, Temporal.Asynchronous.Precedence
____Arg1____
572..613
4,3,3,0;4,3,3,1,0;4,3,3,1,1;4,3,3,1,2,0;4,3,3,1,2,1,0;4,3,3,1,2,1,1
#### Text ####
transplanting a toad's gene into bacteria
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
615..620;626..647
4,3,3,1,2,1,2,0;4,3,3,1,2,1,2,1,1;4,3,3,1,2,1,2,1,2
#### Text ####
which reproduced toad genes
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Explicit____
651..655
5,0,0
#### Text ####
When
##############
#### Features ####
Wr, Comm, Null, Null
when, Temporal.Synchrony
____Arg1____
737..758
5,1;5,2;5,3;5,4
#### Text ####
they saw dollar signs
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
656..735
5,0,1
#### Text ####
Boyer met Robert Swanson, an M.I.T.-trained chemist-turned-entrepreneur in 1976
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Implicit____
760
6
#### Features ####
Wr, Comm, Null, Null
so, Contingency.Cause.Result
____Arg1____
651..758
5
#### Text ####
When Boyer met Robert Swanson, an M.I.T.-trained chemist-turned-entrepreneur in 1976, they saw dollar signs
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
760..839
6
#### Text ####
With $500 apiece and an injection of outside capital, they formed Genentech Inc
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Implicit____
841
7
#### Features ####
Wr, Comm, Null, Null
and, Temporal.Synchrony
thus, Contingency.Cause.Result
____Arg1____
760..839
6
#### Text ####
With $500 apiece and an injection of outside capital, they formed Genentech Inc
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
841..874
7
#### Text ####
Commercial gene-splicing was born
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____AltLex____
965..986
9,0,0,0;9,0,0,1,1,1,0;9,0,0,1,1,1,1,0;9,0,0,1,1,1,1,1,0
#### Text ####
The next to be cloned
##############
#### Features ####
Wr, Comm, Null, Null
Temporal.Asynchronous.Precedence
____Arg1____
878..963
8
#### Text ####
Genentech's first product, a brain protein called somatostatin, proved its technology
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
965..1132
9
#### Text ####
The next to be cloned, human insulin, had market potential and Genentech licensed it to Eli Lilly, which produced 80% of the insulin used by 1.5 million U.S. diabetics
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Explicit____
1024..1027
9,1
#### Text ####
and
##############
#### Features ####
Wr, Comm, Null, Null
and, Expansion.Conjunction, Contingency.Cause.Result
____Arg1____
965..1023
9,0
#### Text ####
The next to be cloned, human insulin, had market potential
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
1028..1132
9,2
#### Text ####
Genentech licensed it to Eli Lilly, which produced 80% of the insulin used by 1.5 million U.S. diabetics
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Explicit____
1386..1397
12,0
#### Text ####
Nonetheless
##############
#### Features ####
Wr, Comm, Null, Null
nonetheless, Comparison.Concession.Contra-expectation
____Arg1____
1228..1384
11
#### Text ####
At the time, Genentech had only one profitable year behind it (a modest $116,000 on revenue of $2.6 million in 1979) and no product of its own on the market
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
1399..1491
12,1;12,2;12,3;12,4
#### Text ####
the $36 million issue they floated in 1980 opened at $35 and leaped to $89 within 20 minutes
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Explicit____
1563..1575
14,0,0,1,1
#### Text ####
for instance
##############
#### Features ####
Wr, Comm, Null, Null
for instance, Expansion.Instantiation
____Arg1____
1495..1544
13
#### Text ####
The trip from the test tube was not without snags
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
1546..1561;1577..1738
14,0,0,0;14,0,0,1,0;14,0,0,1,2;14,0,0,2;14,0,0,3;14,0,1;14,1;14,2;14,3;14,4;14,5
#### Text ####
Boyer and Cohen both still university researchers, had to be talked into applying for a patent on their gene-splicing technique -- and then the Patent Office refused to grant it
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Explicit____
1692..1695
14,2
#### Text ####
and
##############
#### Features ####
Wr, Comm, Null, Null
and, Expansion.Conjunction
____Arg1____
1546..1688
14,0
#### Text ####
Boyer and Cohen, for instance, both still university researchers, had to be talked into applying for a patent on their gene-splicing technique
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
1696..1738
14,3;14,4;14,5
#### Text ####
then the Patent Office refused to grant it
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Explicit____
1696..1700
14,3
#### Text ####
then
##############
#### Features ####
Wr, Comm, Null, Null
then, Temporal.Asynchronous.Precedence
____Arg1____
1546..1688
14,0
#### Text ####
Boyer and Cohen, for instance, both still university researchers, had to be talked into applying for a patent on their gene-splicing technique
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
1692..1695;1701..1738
14,2;14,4;14,5
#### Text ####
and the Patent Office refused to grant it
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Explicit____
1755..1762
15,2
#### Text ####
in turn
##############
#### Features ####
Wr, Comm, Null, Null
in turn, Temporal.Asynchronous.Precedence
____Arg1____
1692..1738
14,2;14,3;14,4;14,5
#### Text ####
and then the Patent Office refused to grant it
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
1740..1753;1764..1802
15,0;15,1;15,3;15,4,0;15,4,1,0;15,4,1,1;15,4,1,2;15,4,1,3;15,5
#### Text ####
That judgment was reversed by the U.S. Supreme Court
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Implicit____
1976
17
#### Features ####
Wr, Comm, Null, Null
for example, Expansion.Instantiation
____Arg1____
1916..1974
16
#### Text ####
Gene-splicing now is an integral part of the drug business
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
1976..2058
17
#### Text ####
Genentech's 1988 sales were $335 million, both from licensing and its own products
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
